Home -> Law Blog Directory -> Personal Injury Law Blogs -> A Georgia Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: A Georgia LawyerFosamax: First Trial Approaches
The Fosamax plaintiffs claim Merck misrepresented the drug?s safety and failed to warn doctors and patients that it might hamper blood flow to the jaw, causing jawbone-tissue death and leading to partial removal in some patients. Jawbone tissue death is called osteonecrosis of the jaw, or ONJ.
The patients claim Merck didn?t sufficiently warn about the drug?s risks when it changed the label in 2005. ?They were the only drug company not to use the language that the FDA requested,? O?Brien said, referring to the U.S. Food and Drug Administration.
Merck says the drug is safe and effective.
Full post as published by A Georgia Lawyer on August 11, 2009 (boomark / email).
Fosamax
Possible Link with Esophageal Cancer
Fosamax ONJ
allegedly causing Osteonecrosis of the Jaw in cancer patients.
Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin.
The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...

First Fosamax Trial to Begin Next Week
First Fosamax Trial Against Merck Begins Today
First Fosamax Trial Scheduled to Begin August 11
Possible Good News for Those Taking the Oral Form of Fosamax
Fosamax Linked to Esophageal Cancer


![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=d595d21b-d478-4c65-b626-5461d3012841)







